Dr. Adam S. Plotkin, MD

Dr. Plotkin practices at Palm Beach Dermatology Group in Delray Beach, Florida.

Dr. Plotkin's NPI, 1306896105, was assigned on May 11, 2006. Dr. Plotkin graduated from Perelman School of Medicine - Philadelphia in 1992. Dr. Plotkin holds Florida license ME0072886.

Dr. Plotkin's primary practice is Palm Beach Dermatology Group, at 5210 Linton Blvd Suite 307 Suite 307, Delray Beach, FL 33484-6500. The practice phone is (561) 499-0660.

Dr. Plotkin's primary practice is Palm Beach Dermatology Group in Delray Beach, Florida. Dr. Plotkin is also affiliated with Heart of the Rockies Regional Medical Center. The medical group on file is Palm Beach Dermatology Group. Dmand AI also links Dr. Plotkin to 7 more medical groups, 4 group practices and clinics, 3 physician offices, 1 home health agency and 1 skilled nursing facility, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Plotkin practices, 11 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Plotkin's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Plotkin is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Plotkin's licenses on file in 15 states: Florida, California, Colorado, District of Columbia, New Hampshire, New Jersey, Nevada, South Carolina, Tennessee, Washington, Connecticut, Illinois, Massachusetts, Michigan and North Carolina.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cold sores or genital herpes, contact dermatitis, corns and calluses, facial skin infection and hives among the conditions Dr. Plotkin treats.

CMS data shows 17,600 Medicare services from Dr. Plotkin across 28 procedure codes in 2024, for 1,900 Medicare patients. Medicare paid $1,345,732 for them. Every service was in an office.

CMS counts 1,900 Medicare patients who saw Dr. Plotkin in 2024. The largest group is 75 to 84, with 923 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 2% are also on Medicaid. Their average risk score is 1.42, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Plotkin's median patient age at 80, with 54% women.

In 2024, Dr. Plotkin wrote 2,568 Medicare Part D claims for 928 patients. 97% of them were for generic drugs. CMS names the drug for 2,383 of them, across 28 drugs with 11 or more claims each, at $183,728 in total drug cost. In 2023, CMS named 2,269 claims across 32 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Plotkin for performance year 2024, reported as part of a group. Dr. Plotkin accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 5,154 procedures of removal of skin lesions by Dr. Plotkin, more than 99% of the clinicians it reports for that procedure.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 3 papers to Dr. Plotkin in 2020. Dr. Plotkin's most frequent co-author is David A. Katzka, MD.

Dmand AI links Dr. Plotkin to 2 clinical trials. Conditions studied include Psoriasis, Rombo syndrome and Skin Diseases, Papulosquamous. Open Payments lists research payments to Dr. Plotkin that name 1 trial.

CMS Open Payments shows 218 general payments to Dr. Plotkin from 35 drug and device companies from 2016 to 2025. Honoraria make up the largest share, 40% of the total. Sun Pharmaceutical Industries Inc. paid the most, $10,681. It also lists 3 research payments totaling $6,175 from 2023 to 2025, naming 1 clinical trial.

Dmand AI lists 3 awards for Dr. Plotkin.

Dr. Plotkin graduated from Perelman School of Medicine - Philadelphia in 1992. Dr. Plotkin is a member of AAD.

Dr. Plotkin is in network with 23 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 16. Check the plan with the practice before a visit.